Enter the first few characters of Company and click 'Go'

Transgene Biotek Ltd. Company History and Annual Growth Details

V. COMPANY, MANAGEMENT & PROJECT

(1) HISTORY, MAIN OBJECTS & PRESENT BUSINESS OF THE COMPANY

Transgene Biotek Limited incorporated as a Private Limited
Company on 1st March, 1990, was subsequently converted into
Public Limited on 28th November, 1990. The Company is
engaged in the research and development and manufacture of
various medical reagents both Bio-chemical and
Immuno-Diagnostic reagents for the qualitative and
quantitative estimation of bio-chemical parameters and
diagnosis of diseases respectively

MAIN OBJECTS OF THE COMPANY

The main objects of the company as set out in the
Memorandum of Association are as under;

1. To undertake, promote, assist or engage in all kinds of
development work required in the field of Bio-Technology,
to develop the entire spectrum of diagnosis by Enzymatic or
Chemical methods useful in Bio-Chemical assays, ELISA and
EIA systems and to develop the monitoring equipment for
diagnostic systems.

2. To develop, manufacture, buy, sell, import, export, and
deal in all types of vaccines, enzyme sensors for medical
and environment applications DNA related products like
immuno modulators Genetic Engineering in medical and health
sectors, antigens of infection agents.

3. To set up laboratories develop, extract, import, export
buy sell, deal in hire, the technology, process methods
systems and to manufacture import, export buy sell, deal in
hire the equipment and instruments, chemicals and enzymes
which are capable of being used in the fields of
Bio-Technology genetic engineering and diagnosis.

4. To carry on the business of manufacturing, producing,
refining, developing, processing, or otherwise acquiring,
buying, selling, importing, exporting, marketing and
generally dealing in all kinds of drugs, medicines,
pharmaceuticals, antibiotics, herbal, bacteriogical, and
biological products, chemicals of all kinds, laboratory
reagents and other preparations, compounds and articles,
all kinds of products and by-products arising there from
and in connection there with and all implements substances,
apparatus, materials, and things incidental to or useful in
connection with any of such business.

PRESENT BUSINESS

The company has set up facilities for manufacture of
Biochemical and Immuno diagnostic (ELISA, Latex
agglutination & MIC ) reagents with present aggregate
installed capacity of 168 lacs tests in Anrich Industrial
Estate, Bollarum Medak dist. Andhra Pradesh.

FINANCIAL PERFORMANCE OF THE COMPANY

The company commenced commercial production from 1st OCT,
'93.

-----------------------------------------------------------
1993-94
-----------------------------------------------------------
Capacity utilisation (%) 45.00
Production 94.68
Sales 252.91
Cost of production 177.31
PBIDT 75.78
Interest 41.91
Depreciation 13.44
PBT 20.42
PAT 20.42
Share Capital 340.00
Reserves 20.42
EPS (Rs) 0.60
Book Value 10.60
Break Even Point 36.68
----------------------------------------------------------

2011

- Company has set up a wholly-owned subsidiary Company in Hong Kong by the name "Transgene Biotek HK Ltd.".

2012
-"Transgene readying to launch one of its block-buster drugs - TrabiDHA (DHA) formulations."

2013
-Transgene signs a Joint Venture agreement with Atral Cipan of Portugal involving the technology transfer of Tacrolimus by Transgene.
-Transgene Biotek becomes the worldÂs first company to create and launch 50% algal DHA oil, and 20% algal DHA powder.

2014
-S/Sri Sarang Subhash Puranik and Shyam Shankar Das would be appointed as Directors of the company.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article